These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18544102)

  • 1. Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation.
    D'Amato E; Tammaro P; Craig TJ; Tosi A; Giorgetti R; Lorini R; Ashcroft FM
    Diabet Med; 2008 Jun; 25(6):651-6. PubMed ID: 18544102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
    Flechtner I; de Lonlay P; Polak M
    Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.
    Massa O; Iafusco D; D'Amato E; Gloyn AL; Hattersley AT; Pasquino B; Tonini G; Dammacco F; Zanette G; Meschi F; Porzio O; Bottazzo G; Crinó A; Lorini R; Cerutti F; Vanelli M; Barbetti F;
    Hum Mutat; 2005 Jan; 25(1):22-7. PubMed ID: 15580558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
    Gloyn AL; Pearson ER; Antcliff JF; Proks P; Bruining GJ; Slingerland AS; Howard N; Srinivasan S; Silva JM; Molnes J; Edghill EL; Frayling TM; Temple IK; Mackay D; Shield JP; Sumnik Z; van Rhijn A; Wales JK; Clark P; Gorman S; Aisenberg J; Ellard S; Njølstad PR; Ashcroft FM; Hattersley AT
    N Engl J Med; 2004 Apr; 350(18):1838-49. PubMed ID: 15115830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects.
    Shimomura K; Girard CA; Proks P; Nazim J; Lippiat JD; Cerutti F; Lorini R; Ellard S; Hattersley AT; Barbetti F; Ashcroft FM
    Diabetes; 2006 Jun; 55(6):1705-12. PubMed ID: 16731833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.
    Gloyn AL; Diatloff-Zito C; Edghill EL; Bellanné-Chantelot C; Nivot S; Coutant R; Ellard S; Hattersley AT; Robert JJ
    Eur J Hum Genet; 2006 Jul; 14(7):824-30. PubMed ID: 16670688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities.
    Rica I; Luzuriaga C; Pérez de Nanclares G; Estalella I; Aragonés A; Barrio R; Bilbao JR; Carlés C; Fernández C; Fernández JM; Fernández-Rebollo E; Gastaldo E; Giralt P; Gomez Vida JM; Gutiérrez A; López Siguero JP; Martínez-Aedo MJ; Muñoz M; Prieto J; Rodrigo J; Vargas F; Castano L
    Diabet Med; 2007 Jul; 24(7):707-13. PubMed ID: 17490422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.
    Shimomura K; Hörster F; de Wet H; Flanagan SE; Ellard S; Hattersley AT; Wolf NI; Ashcroft F; Ebinger F
    Neurology; 2007 Sep; 69(13):1342-9. PubMed ID: 17652641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
    Proks P; Girard C; Baevre H; Njølstad PR; Ashcroft FM
    Diabetes; 2006 Jun; 55(6):1731-7. PubMed ID: 16731836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
    Bremer AA; Ranadive S; Lustig RH
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):236-9. PubMed ID: 18221420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus.
    Yorifuji T; Nagashima K; Kurokawa K; Kawai M; Oishi M; Akazawa Y; Hosokawa M; Yamada Y; Inagaki N; Nakahata T
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3174-8. PubMed ID: 15784703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KCNJ11 activating mutations cause both transient and permanent neonatal diabetes mellitus in Cypriot patients.
    Ioannou YS; Ellard S; Hattersley A; Skordis N
    Pediatr Diabetes; 2011 Mar; 12(2):133-7. PubMed ID: 21352428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low doses of sulphonyluria as a successful replacement for insulin therapy in a patient with neonatal diabetes due to a mutation of KCNJ11 gene encoding Kir6.2].
    Ille J; Putarek NR; Radica A; Hattersley A; Ellard S; Dumić M
    Lijec Vjesn; 2010; 132(3-4):90-3. PubMed ID: 20540435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of two novel frameshift mutations in the KCNJ11 gene in two Italian patients affected by Congenital Hyperinsulinism of Infancy.
    Biagiotti L; Proverbio MC; Bosio L; Gervasi F; Rovida E; Cerioni V; Bove M; Valin PS; Albarello L; Zamproni I; Grassi S; Doglioni C; Mora S; Chiumello G; Biunno I
    Exp Mol Pathol; 2007 Aug; 83(1):59-64. PubMed ID: 17316607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation.
    Slingerland AS; Hurkx W; Noordam K; Flanagan SE; Jukema JW; Meiners LC; Bruining GJ; Hattersley AT; Hadders-Algra M
    Diabet Med; 2008 Mar; 25(3):277-81. PubMed ID: 18307455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.
    Ješić MM; Ješić MD; Maglajlić S; Sajić S; Necić S
    Diabetes Res Clin Pract; 2011 Jan; 91(1):e1-3. PubMed ID: 21056492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal diabetes mellitus: description of two Puerto Rican children with KCNJ11 activating gene mutation.
    Nieves-Rivera F; González-Pijem L
    P R Health Sci J; 2011 Jun; 30(2):87-9. PubMed ID: 21682153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of mutations in the Kir6.2 subunit of the K(ATP) channel.
    Flanagan SE; Ellard S
    Methods Mol Biol; 2008; 491():235-45. PubMed ID: 18998097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapsing diabetes can result from moderately activating mutations in KCNJ11.
    Gloyn AL; Reimann F; Girard C; Edghill EL; Proks P; Pearson ER; Temple IK; Mackay DJ; Shield JP; Freedenberg D; Noyes K; Ellard S; Ashcroft FM; Gribble FM; Hattersley AT
    Hum Mol Genet; 2005 Apr; 14(7):925-34. PubMed ID: 15718250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity.
    Malecki MT; Skupien J; Klupa T; Wanic K; Mlynarski W; Gach A; Solecka I; Sieradzki J
    Diabetes Care; 2007 Jan; 30(1):147-9. PubMed ID: 17192350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.